Ahmad Al-Shareef

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The objective of this study was to determine the outcome of patients treated with recombinant activated factor VII (rFVIIa) to promote haemostasis in intractable bleeding associated with trauma injury or other causes. The medical records of 44 consecutive patients treated with rFVIIa were retrospectively reviewed for blood product use before and after(More)
  • 1